Home › NDC Lookup › Labelers › Glaxosmithkline Biologicals Sa

Glaxosmithkline Biologicals Sa NDCs and Package Codes

This page lists NDC package records associated with labeler code 58160 (Glaxosmithkline Biologicals Sa) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.

Key stats

28
Package NDCs
39
Products
38
Active listings
1
Discontinued
18
Ingredients
0
Therapeutic classes
5
Dosage forms
0
With NADAC pricing

Portfolio

Top ingredients
Respiratory Syncytial Virus Vaccin... 9
Haemophilus b Conjugate Vaccine (T... 4
Hepatitis B Vaccine (Recombinant) 4
Zoster Vaccine Recombinant, Adjuva... 4
influenza virus vaccine 2
Tetanus Toxoid, Reduced Diphtheria... 2
Meningococcal (Groups A, C, Y and... 2
Hepatitis A Vaccine 2
NEISSERIA MENINGITIDIS SEROGROUP B... 1
Meningococcal (Groups A, B, C, W a... 1
By dosage form
KIT 19
INJECTION, SUSPENSION 10
SUSPENSION 5
INJECTION, SOLUTION 4
SOLUTION 1

Browse records — 39 products

Drug / product Billing NDC NADAC / unit Status
Arepanrix Influenza A H5 Monovalent Vaccine KIT GlaxoSmithKline · NDC 58160-0742-25 · 1 KIT in 1 CARTON (58160-742-25) * 10 VIAL in 1 CARTON (58160-753-19) / 2.5 mL in 1 VIAL (58160-753-01) * 10 VIAL in 1 CARTON (58160-855-19) / 2.5 mL in 1 VIAL (58160-855-01) 58160-0742-25 — On market View →
Arexvy Respiratory Syncytial Virus Vaccine Recombinant, Adjuvanted KIT GlaxoSmithKline · NDC 58160-0882-12 · 1 KIT in 1 CARTON (58160-882-12) * .5 mL in 1 VIAL (58160-719-03) * .5 mL in 1 SYRINGE (58160-749-07) 58160-0882-12 — On market View →
Arexvy Respiratory Syncytial Virus Vaccine Recombinant, Adjuvanted KIT GlaxoSmithKline · NDC 58160-0848-11 · 1 KIT in 1 CARTON (58160-848-11) * .5 mL in 1 VIAL (58160-723-03) * .5 mL in 1 VIAL (58160-744-03) 58160-0848-11 — On market View →
Arexvy Respiratory Syncytial Virus Vaccine Recombinant, Adjuvanted KIT GlaxoSmithKline · NDC 58160-0894-15 · 1 KIT in 1 CARTON (58160-894-15) * .5 mL in 1 VIAL (58160-719-03) * .5 mL in 1 SYRINGE (58160-749-07) 58160-0894-15 — On market View →
Arexvy Respiratory Syncytial Virus Vaccine Recombinant, Adjuvanted KIT GlaxoSmithKline · NDC 58160-0882-12 · 1 KIT in 1 CARTON (58160-882-12) * .5 mL in 1 VIAL (58160-719-03) * .5 mL in 1 SYRINGE (58160-749-07) 58160-0882-12 — On market View →
Arexvy Respiratory Syncytial Virus Vaccine Recombinant, Adjuvanted KIT GlaxoSmithKline · NDC 58160-0894-15 · 1 KIT in 1 CARTON (58160-894-15) * .5 mL in 1 VIAL (58160-719-03) * .5 mL in 1 SYRINGE (58160-749-07) 58160-0894-15 — On market View →
Arexvy Respiratory Syncytial Virus Vaccine Recombinant, Adjuvanted KIT GlaxoSmithKline · NDC 58160-0848-11 · 1 KIT in 1 CARTON (58160-848-11) * .5 mL in 1 VIAL (58160-723-03) * .5 mL in 1 VIAL (58160-744-03) 58160-0848-11 — On market View →
Arexvy Respiratory Syncytial Virus Vaccine Recombinant, Adjuvanted KIT GlaxoSmithKline · NDC 58160-0882-12 · 1 KIT in 1 CARTON (58160-882-12) * .5 mL in 1 VIAL (58160-719-03) * .5 mL in 1 SYRINGE (58160-749-07) 58160-0882-12 — On market View →
Arexvy Respiratory Syncytial Virus Vaccine Recombinant, Adjuvanted KIT GlaxoSmithKline · NDC 58160-0848-11 · 1 KIT in 1 CARTON (58160-848-11) * .5 mL in 1 VIAL (58160-723-03) * .5 mL in 1 VIAL (58160-744-03) 58160-0848-11 — On market View →
Arexvy Respiratory Syncytial Virus Vaccine Recombinant, Adjuvanted KIT GlaxoSmithKline · NDC 58160-0894-15 · 1 KIT in 1 CARTON (58160-894-15) * .5 mL in 1 VIAL (58160-719-03) * .5 mL in 1 SYRINGE (58160-749-07) 58160-0894-15 — On market View →
AS03 INJECTION, SOLUTION GlaxoSmithKline · NDC 58160-0855-19 · 10 VIAL in 1 CARTON (58160-855-19) / 2.5 mL in 1 VIAL (58160-855-01) 58160-0855-19 — On market View →
Bexsero NEISSERIA MENINGITIDIS SEROGROUP B NHBA FUSION PROTEIN ANTIGEN, NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIGEN and NEISSERIA MENINGITIDIS SEROGROUP B NADA 50 ug/.5mL; 50 ug/.5mL; 50 ug/.5mL INJECTION, SUSPENSION GlaxoSmithKline · NDC 58160-0976-20 · 10 SYRINGE in 1 CARTON (58160-976-20) / .5 mL in 1 SYRINGE (58160-976-02) 58160-0976-20 — On market View →
BOOSTRIX Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed 5 [iU]/.5mL; 2.5 [iU]/.5mL; 8 ug/.5mL SUSPENSION GlaxoSmithKline · NDC 58160-0842-11 · 90715 · 10 VIAL in 1 CARTON (58160-842-11) / .5 mL in 1 VIAL (58160-842-01) 58160-0842-11 — On market View →
BOOSTRIX Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed 5 [iU]/.5mL; 2.5 [iU]/.5mL; 8 ug/.5mL SUSPENSION GlaxoSmithKline · NDC 58160-0842-11 · 90715 · 10 VIAL in 1 CARTON (58160-842-11) / .5 mL in 1 VIAL (58160-842-01) 58160-0842-11 — On market View →
ENGERIX-B Hepatitis B Vaccine (Recombinant) 10 ug/.5mL INJECTION, SUSPENSION GlaxoSmithKline · NDC 58160-0820-52 · 10 SYRINGE in 1 CARTON (58160-820-52) / .5 mL in 1 SYRINGE (58160-820-43) 58160-0820-52 — On market View →
ENGERIX-B Hepatitis B Vaccine (Recombinant) 20 ug/mL INJECTION, SUSPENSION GlaxoSmithKline · NDC 58160-0821-11 · 10 VIAL in 1 CARTON (58160-821-11) / 1 mL in 1 VIAL (58160-821-01) 58160-0821-11 — On market View →
ENGERIX-B Hepatitis B Vaccine (Recombinant) 20 ug/mL INJECTION, SUSPENSION GlaxoSmithKline · NDC 58160-0821-11 · 10 VIAL in 1 CARTON (58160-821-11) / 1 mL in 1 VIAL (58160-821-01) 58160-0821-11 — On market View →
ENGERIX-B Hepatitis B Vaccine (Recombinant) 10 ug/.5mL INJECTION, SUSPENSION GlaxoSmithKline · NDC 58160-0820-52 · 10 SYRINGE in 1 CARTON (58160-820-52) / .5 mL in 1 SYRINGE (58160-820-43) 58160-0820-52 — On market View →
FLUARIX 2025/2026 influenza virus vaccine 15 ug/.5mL; 15 ug/.5mL SUSPENSION GlaxoSmithKline · NDC 58160-0912-52 · 10 SYRINGE in 1 CARTON (58160-912-52) / .5 mL in 1 SYRINGE (58160-912-41) 58160-0912-52 — Discontinued View →
FLUARIX 2026/2027 influenza virus vaccine 15 ug/.5mL; 15 ug/.5mL SUSPENSION GlaxoSmithKline · NDC 58160-0725-52 · 10 SYRINGE in 1 CARTON (58160-725-52) / .5 mL in 1 SYRINGE (58160-725-41) 58160-0725-52 — On market View →
HAVRIX Hepatitis A Vaccine 1440 [iU]/mL INJECTION, SUSPENSION GlaxoSmithKline · NDC 58160-0826-52 · 90632 · 10 SYRINGE in 1 CARTON (58160-826-52) / 1 mL in 1 SYRINGE (58160-826-43) 58160-0826-52 — On market View →
HAVRIX Hepatitis A Vaccine 720 [iU]/.5mL INJECTION, SUSPENSION GlaxoSmithKline · NDC 58160-0825-52 · 10 SYRINGE in 1 CARTON (58160-825-52) / .5 mL in 1 SYRINGE (58160-825-43) 58160-0825-52 — On market View →
Hiberix Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate) KIT GlaxoSmithKline · NDC 58160-0726-15 · 1 KIT in 1 CARTON (58160-726-15) * .5 mL in 1 VIAL (58160-816-03) * .85 mL in 1 SYRINGE (58160-817-02) 58160-0726-15 — On market View →
Hiberix Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate) KIT GlaxoSmithKline · NDC 58160-0818-11 · 1 KIT in 1 CARTON (58160-818-11) * 10 VIAL in 1 CARTON (58160-816-05) / .5 mL in 1 VIAL (58160-816-01) * 10 VIAL in 1 PACKAGE (58160-817-05) / .85 mL in 1 VIAL (58160-817-01) 58160-0818-11 — On market View →
Hiberix Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate) KIT GlaxoSmithKline · NDC 58160-0818-11 · 1 KIT in 1 CARTON (58160-818-11) * 10 VIAL in 1 CARTON (58160-816-05) / .5 mL in 1 VIAL (58160-816-01) * 10 VIAL in 1 PACKAGE (58160-817-05) / .85 mL in 1 VIAL (58160-817-01) 58160-0818-11 — On market View →
Hiberix Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate) KIT GlaxoSmithKline · NDC 58160-0726-15 · 1 KIT in 1 CARTON (58160-726-15) * .5 mL in 1 VIAL (58160-816-03) * .85 mL in 1 SYRINGE (58160-817-02) 58160-0726-15 — On market View →
INFANRIX Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed 10 [iU]/.5mL; 25 [iU]/.5mL; 25 ug/.5mL SUSPENSION GlaxoSmithKline · NDC 58160-0810-52 · 10 SYRINGE in 1 CARTON (58160-810-52) / .5 mL in 1 SYRINGE (58160-810-43) 58160-0810-52 — On market View →
KINRIX Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine 25 [iU]/.5mL; 10 [iU]/.5mL; 25 [iU]/.5mL INJECTION, SUSPENSION GlaxoSmithKline · NDC 58160-0812-52 · 10 SYRINGE in 1 CARTON (58160-812-52) / .5 mL in 1 SYRINGE (58160-812-43) 58160-0812-52 — On market View →
Menveo Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine 10 ug/.5mL; 5 ug/.5mL INJECTION, SOLUTION GlaxoSmithKline · NDC 58160-0827-30 · 10 VIAL in 1 CARTON (58160-827-30) / .5 mL in 1 VIAL (58160-827-03) 58160-0827-30 — On market View →
Menveo Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine KIT GlaxoSmithKline · NDC 58160-0955-09 · 1 KIT in 1 CARTON (58160-955-09) * .5 mL in 1 VIAL, SINGLE-DOSE (58160-958-01) * .5 mL in 1 VIAL, SINGLE-DOSE (58160-959-01) 58160-0955-09 — On market View →
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.